PL347542A1 - Therapeutic product and its use - Google Patents

Therapeutic product and its use

Info

Publication number
PL347542A1
PL347542A1 PL99347542A PL34754299A PL347542A1 PL 347542 A1 PL347542 A1 PL 347542A1 PL 99347542 A PL99347542 A PL 99347542A PL 34754299 A PL34754299 A PL 34754299A PL 347542 A1 PL347542 A1 PL 347542A1
Authority
PL
Poland
Prior art keywords
therapeutic product
therapeutic
product
Prior art date
Application number
PL99347542A
Other languages
English (en)
Inventor
Hazel Bardsley
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9826537.4A external-priority patent/GB9826537D0/en
Priority claimed from GBGB9826536.6A external-priority patent/GB9826536D0/en
Priority claimed from GBGB9826535.8A external-priority patent/GB9826535D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of PL347542A1 publication Critical patent/PL347542A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL99347542A 1998-12-02 1999-12-02 Therapeutic product and its use PL347542A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9826537.4A GB9826537D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
GBGB9826536.6A GB9826536D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
GBGB9826535.8A GB9826535D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
PCT/GB1999/004021 WO2000032558A1 (en) 1998-12-02 1999-12-02 Therapeutic product and its use

Publications (1)

Publication Number Publication Date
PL347542A1 true PL347542A1 (en) 2002-04-08

Family

ID=27269570

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99347542A PL347542A1 (en) 1998-12-02 1999-12-02 Therapeutic product and its use

Country Status (12)

Country Link
EP (1) EP1135361A1 (xx)
JP (1) JP2002531431A (xx)
KR (1) KR20010080364A (xx)
CN (1) CN1329590A (xx)
AU (1) AU1400100A (xx)
BR (1) BR9915873A (xx)
CA (1) CA2350635A1 (xx)
HU (1) HUP0104420A2 (xx)
IL (1) IL142778A0 (xx)
NO (1) NO20012738L (xx)
PL (1) PL347542A1 (xx)
WO (1) WO2000032558A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1164601A (en) 1999-11-09 2001-06-06 Darwin Discovery Limited Therapeutic use and formulation
BR0114395A (pt) * 2000-10-03 2005-08-16 Penwest Pharmaceuticals Compan Composição farmacêutica para administração por suprimento via oral
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
WO2003048113A1 (en) 2001-11-30 2003-06-12 Sepracor Inc. Tramadol analogs and uses thereof
RU2008113439A (ru) 2005-09-09 2009-10-20 Лабофарм Инк. (CA) Композиции с замедленным высвобождением лекарственного средства
NZ579170A (en) 2007-02-12 2012-05-25 Dmi Biosciences Inc Reducing side effects of tramadol
BRPI0811639A2 (pt) * 2007-05-31 2014-09-30 Sepracor Inc Cicloaquilaminas fenil substituídas como inibidores da recaptação de monoamina
JOP20190251A1 (ar) * 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
WO2019113079A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
WO2019113084A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
BR112021024380A2 (pt) 2019-06-04 2022-04-19 Sunovion Pharmaceuticals Inc Formulações de liberação modificadas e usos das mesmas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
BR9808325A (pt) * 1997-03-11 2000-05-16 Darwin Discovery Ltd Formas de dosagem compreendendo porções separadas de r- e senanciÈmeros
DE19807535A1 (de) * 1998-02-21 1999-08-26 Asta Medica Ag Pharmazeutische Kombinationen mit Tramadol

Also Published As

Publication number Publication date
NO20012738D0 (no) 2001-06-01
WO2000032558A1 (en) 2000-06-08
AU1400100A (en) 2000-06-19
EP1135361A1 (en) 2001-09-26
CA2350635A1 (en) 2000-06-08
JP2002531431A (ja) 2002-09-24
CN1329590A (zh) 2002-01-02
KR20010080364A (ko) 2001-08-22
NO20012738L (no) 2001-06-01
BR9915873A (pt) 2001-08-21
HUP0104420A2 (en) 2002-08-28
IL142778A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
GB9415125D0 (en) Surgical product and its use
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
PL347542A1 (en) Therapeutic product and its use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
GB9615435D0 (en) Spray-dried product and its therapeutic use
GB9816897D0 (en) Therapeutic use
GB9810920D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB9616504D0 (en) Therapeutic product and its use
GB9826536D0 (en) Therapeutic product and its use
GB9826539D0 (en) Therapeutic product and its use
GB9826537D0 (en) Therapeutic product and its use
GB9826535D0 (en) Therapeutic product and its use
GB9821179D0 (en) Therapeutic use
GB9811624D0 (en) Therapeutic use
GB9929581D0 (en) Comjpositions and their use
GB9616509D0 (en) Therapeutic product and its use
GB9616506D0 (en) Therapeutic product and its use
GB9616508D0 (en) Therapeutic product and its use
GB9616507D0 (en) Therapeutic product and its use
GB9616510D0 (en) Therapeutic product and its use
GB9616505D0 (en) Therapeutic product and its use
GB9616823D0 (en) Therapeutic product and its use
GB9616550D0 (en) Therapeutic product and its use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)